Sevoflurane-induced hyperglycemia is attenuated by salsalate in obese insulin-resistant mice
ConclusionThese data show that salsalate can reduce sevoflurane-induced hyperglycemia in mice. This indicates that salsalate may represent a new class of therapeutics that, in addition to its anti-inflammatory and analgesic properties, may be useful to reduce perioperative hyperglycemia.
Source: Canadian Journal of Anesthesia - Category: Anesthesiology Source Type: research
More News: Anesthesia | Anesthesiology | Canada Health | Eating Disorders & Weight Management | Insulin | Obesity | Sevoflurane | Statistics | Ultane